Navigation Links
Powerful genome ID method extended to humans

A mathematical discovery has extended the reach of a novel genome mapping method to humans, potentially giving cancer biology a faster and more cost-effective tool than traditional DNA sequencing.

A student-led group from the laboratory of Michael Waterman, USC University Professor in molecular and computational biology, has developed an algorithm to handle the massive amounts of data created by a restriction mapping technology known as "optical mapping." Restriction maps provide coordinates on chromosomes analogous to mile markers on freeways.

Lead author Anton Valouev, a recent graduate of Waterman's lab and now a postdoctoral fellow at Stanford University, said the algorithm makes it possible to optically map the human genome.

"It carries tremendous benefits for medical applications, specifically for finding genomic abnormalities," he said.

The algorithm appears in this week's PNAS Early Edition.

Optical mapping was developed at New York University in the late 1990s by David Schwartz, now a professor of chemistry and genetics at the University of Wisconsin-Madison. Schwartz and a collaborator at Wisconsin, Shiguo Zhou, co-authored the PNAS paper.

The power of optical mapping lies in its ability to reveal the size and large-scale structure of a genome. The method uses fluorescence microscopy to image individual DNA molecules that have been divided into orderly fragments by so-called restriction enzymes.

By imaging large numbers of an organism's DNA molecules, optical mapping can produce a map of its genome at a relatively low cost.

An optical map lacks the minute detail of a genetic sequence, but it makes up for that shortcoming in other ways, said Philip Green, a professor of genome sciences at the University of Washington who edited the PNAS paper.

Geneticists often say that humans have 99.9 percent of their DNA in common. But, Green said, "individuals occasionally have big di
'"/>

Source:University of Southern California


Page: 1 2

Related biology news :

1. Powerful new tool for studying brain development
2. Powerful technique for multiplying adult stem cells may aid therapies
3. Man and mouse share genome structures
4. Whole genome fine map of rice completed
5. Study finds more than one-third of human genome regulated by RNA
6. A bacterial genome reveals new targets to combat infectious disease
7. Scientists decipher genome of fungus that can cause life-threatening infections
8. Highly adaptable genome in gut bacterium key to intestinal health
9. Fleshing out the genome
10. Agilent Technologies new genome analysis technology set to accelerate Australia fight against mesothelioma
11. wFleaBase: the Daphnia genome database

Post Your Comments:
(Date:11/4/2009)..., 2009 Childhood obesity in the United States is ...fourth of advertising on daytime and prime time te...uing questions about the role television plays in ... the Journal of Nutrition Education and Behavior ...ight be a large contributor to the problem. , Re...
(Date:11/4/2009)...., Oct. 19 Spectros, developer and...aging devices which shed light on life-threatening...usive distribution deals for both its T-Stat®...ered include Australia, New Zealand, The Netherla...y, France, Spain, Portugal, Poland, Greece, Turkey...
(Date:11/4/2009)... What,s the cost of saving a teenag...th resulting from prescription medication abuse, t... however, may be unaware that the lock-boxes they,...he ticking timebomb of prescription drugs. That,s ...ty medical supplies, has formed an exclusive partn...
Breaking Biology News(10 mins):TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Spectros Signs New International Distribution Deals 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3New biomarker method could increase the number of diagnostic tests for cancer 9054 1New biomarker method could increase the number of diagnostic tests for cancer 9054 2New biomarker method could increase the number of diagnostic tests for cancer 9054 3New biomarker method could increase the number of diagnostic tests for cancer 9054 4LodgeNet Interactive Announces Completion of Offering of 2457 5 Million of Convertible Preferred Stock 50318 1LodgeNet Interactive Announces Completion of Offering of 2457 5 Million of Convertible Preferred Stock 50318 2LodgeNet Interactive Announces Completion of Offering of 2457 5 Million of Convertible Preferred Stock 50318 3LodgeNet Interactive Announces Completion of Offering of 2457 5 Million of Convertible Preferred Stock 50318 4Oncology Groups Pharmaceutical Services Agreement Enhances Efficiency of Drug Management Program 50315 1Oncology Groups Pharmaceutical Services Agreement Enhances Efficiency of Drug Management Program 50315 2Oncology Groups Pharmaceutical Services Agreement Enhances Efficiency of Drug Management Program 50315 3
...transplant patients reject their new organs requir...accept or reject each other. Xavier Fernndez-Busqu...y of Barcelona, has found the perfect ally in this...ies that grows abundantly from just north of Cape ...icrociona prolifera) has a cell-to-cell recognitio...
... water is a scene with which we,re all familiar. Y...rable amount of time in the water–polar bears, sea...a thick layer of body fat to keep warm. They rely,...ir fur and the densely packed layer of specially a...scopy and polarizing light microsopy, John W. Weis...
... water is a scene with which we,re all familiar. Y...rable amount of time in the water–polar bears, sea...a thick layer of body fat to keep warm. They rely,...ir fur and the densely packed layer of specially a...scopy and polarizing light microsopy, John W. Weis...
Other Biology News:Simple sea sponge helps scientists understand tissue rejection 2Genome Sequence for Haemophilus Influenzae Completed 2Genome Sequence for Haemophilus Influenzae Completed 3Otter adaptations: How do otters remain sleek and warm 2Otter adaptations: How do otters remain sleek and warm 3
(Date:11/8/2009)...9 Complete Genomics, a third-generation human gen...n of a report in the journal Science describing ... analysis of sequence data from three complete hum...enomes sequenced on the proof-of-principle genomic...e to $1,726 for 45x coverage for the samples descr...
(Date:11/6/2009)... Myriant Technologies LLC ("Myriant"), a privately...wable bio-chemicals, Uhde Corporation of America a...e of the world,s leading engineering contractors (...ineering, procurement & construction (EPC) of ...enewable feedstocks. The execution of this allian...
(Date:11/6/2009)...-- Intarcia Therapeutics, Inc. delivered two prese...uous delivery of exenatide) program for the treatm...s Technology Meeting in San Francisco, CA: ,, (...1/SFTU126LOGO ) ,, Continuous Subcutaneous De...cose, HbA1c and Reduces Weight in a 28-day Phase 1...
(Date:11/5/2009)... -- DSM Pharmaceutical Products today announced th...ix, Saint Jean D,Illac, France, where DSM will be ...er for Galenix commercial products on a global bas...ness development opportunities co-marketing Galeni...h of Galenix in drug product development and clini...
Breaking Biology Technology:Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3
...d, CAESAREA, Israel, March 26 Alma Lasers Ltd., ...nd radiofrequency systems,announces important deve...hich is being litigated in the United States Distr...e U.S. Patent and Trademark Office in,Alexandria V...menis,s,patents that are at issue in the litigatio...
...pril 1, 2008, LEVERKUSEN, Germany, and PITTSBURGH...ate MEDRAD, Inc. announced,today that it has succe...ding shares of common stock of Possis Medical, Inc...as advised MEDRAD that, as of the expiration,of th...ay, March 25, 2008,a total of 14,951,550 Possis Me...
...h CyberKnife System to Date, SUNNYVALE, Calif., M...global leader in the field of radiosurgery,announc...fe centers,worldwide are now treating lung cancer ...*. The number of lung cancer patients is growing,s...uals receiving,CyberKnife treatments to date., Lu...
Other Biology Technology:U.S. PTO Reexamining Lumenis Patents 2Bayer HealthCare Affiliate MEDRAD Successfully Completes Tender Offer for Shares of Possis Medical; Announces Subsequent Offering Period 2Bayer HealthCare Affiliate MEDRAD Successfully Completes Tender Offer for Shares of Possis Medical; Announces Subsequent Offering Period 3CyberKnife Radiosurgery Used to Treat Lung Tumors at 90 Percent of Centers Worldwide 2CyberKnife Radiosurgery Used to Treat Lung Tumors at 90 Percent of Centers Worldwide 3CyberKnife Radiosurgery Used to Treat Lung Tumors at 90 Percent of Centers Worldwide 4
Goat Anti-ZBP-89 (S-15) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Enolase from baker's yeast (S. cerevisiae) from Sigma-Aldrich
UNOsphere S Support, 100 ml from Bio-Rad
Baker's yeast (S. cerevisiae) Phosphoglucose isomerase from Sigma-Aldrich
Biology Products: